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Abstract
Background: The sources and measurement of reactive oxygen species (ROS) in intact organs are largely unresolved. This may
be related to methodological problems associated with the techniques currently employed for ROS detection. Electron spin
resonance (ESR) with spin trapping is a specific method for ROS detection, and may address some these technical problems.
Methods: We have established a protocol for the measurement of intravascular ROS release from isolated buffer-perfused and
ventilated rabbit and mouse lungs, combining lung perfusion with the spin probe l-hydroxy-3-carboxy-2,2,5,5-
tetramethylpyrrolidine (CPH) and ESR spectroscopy. We then employed this technique to characterize hypoxia-dependent ROS
release, with specific attention paid to NADPH oxidase-dependent superoxide formation as a possible vasoconstrictor pathway.
Results: While perfusing lungs with CPH over a range of inspired oxygen concentrations (1–21 %), the rate of CP• formation
exhibited an oxygen-dependence, with a minimum at 2.5 % O2. Addition of superoxide dismutase (SOD) to the buffer fluid
illustrated that a minor proportion of this intravascular ROS leak was attributable to superoxide. Stimulation of the lungs by
injection of phorbol-12-myristate-13-acetate (PMA) into the pulmonary artery caused a rapid increase in CP• formation,
concomitant with pulmonary vasoconstriction. Both the PMA-induced CPH oxidation and the vasoconstrictor response were
largely suppressed by SOD. When the PMA challenge was performed at different oxygen concentrations, maximum superoxide
liberation and pulmonary vasoconstriction occurred at 5 % O2. Using a NADPH oxidase inhibitor and NADPH-oxidase deficient
mice, we illustrated that the PMA-induced superoxide release was attributable to the stimulation of NADPH oxidases.
Conclusion:  The perfusion of isolated lungs with CPH is suitable for detection of intravascular ROS release by ESR
spectroscopy. We employed this technique to demonstrate that 1) PMA-induced vasoconstriction is caused "directly" by
superoxide generated from NADPH oxidases and 2) this pathway is pronounced in hypoxia. NADPH oxidases thus may
contribute to the hypoxia-dependent regulation of pulmonary vascular tone.
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Background
Reactive oxygen species (ROS) play an important role in
biological systems. While it is largely accepted that ROS-
mediated oxidative damage occurs under pathophysiolog-
ical conditions, recent evidence also favors a role for ROS
as signaling molecules in physiological processes [1-6]. In
the respiratory system, ROS are involved in pathological
states such as hyperoxia-induced lung injury, sepsis and
ischemia-reperfusion, but may also play a role in the
development of hypoxia-and non-hypoxia-induced pul-
monary hypertension [7-9]. In the context of regulatory
processes of the lung, a growing body of evidence is
emerging indicating that ROS may contribute to signaling
events such as underlying hypoxic pulmonary vasocon-
striction (HPV), an essential mechanism matching lung
perfusion to ventilation in order to optimize pulmonary
gas exchange [10,11]. The question of whether ROS gen-
eration is decreased or paradoxically increased during
alveolar hypoxia, and the sources from which ROS may be
derived under these conditions, are controversial [8,12].
In fact, substantial evidence exists suggesting both
decreases as well as increases, in lung ROS generation dur-
ing alveolar hypoxia [13-15]. Both mitochondria and
NADPH oxidases have been proposed as source(s) of ROS
generation underlying HPV [12,13,15-21].
One possible reason for the discrepancies among the dif-
ferent concepts of hypoxia-dependent ROS generation in
the lung may be the inadequacies of the methods applied.
For example, most of the evidence provided for increased
ROS generation on the cellular level is based on measure-
ments with fluorochromes, such as dihydrorhodamin 123
or 2',7'-dichlorofluorescin diacetate, which have been
shown to be ROS generators themselves under various
conditions [22,23]. In isolated perfused lungs, luminol
and lucigenin, cytochrome c reduction, as well as spin
trapping with 5,5-dimethyl-l-pyrrorine-N-oxide or
sodium 3,5-dibromo-4-nitrosobenzenesulfonate [14,24]
have been used for detection of ROS. These methods are,
however, also prone to pitfalls due to autoxidation of the
substrates, artificial ROS generation by redox cycling
[22,24,25] or the fact that the product interferes with
ascorbate in the tissue [26]. The ROS measurements have
also been performed in rabbit lungs with the spin probe
sodium 3,5-dibromo-4-nitrosobenzenesulfonatesodium
[27]. However, in this investigation, the spin probe was
added to the effluent of the lung, which did not allow
detection of ROS release directly at its source in the lung
vasculature [27].
To overcome several of these problems and to investigate
in particular the role of hypoxia in NADPH oxidase-
derived superoxide release and its role in the regulation of
pulmonary vascular tone, we established a method com-
bining ESR spectroscopy with the spin trapping technique
for measurement of superoxide release from isolated per-
fused and ventilated rabbit and mouse lungs. Superoxide
was detected by the cyclic hydroxylamine l-hydroxy-3-car-
boxy-2,2,5,5-tetramethylpyrrolidine (CPH) which was
recently introduced for quantitative ROS measurements
in biological systems [28]. Employing this agent, ROS for-
mation can be quantified by detection of the correspond-
ing nitroxide radical 3-carboxy-proxyl (CP•) by ESR
spectroscopy [29,30]. After having proven the feasibility
of CPH for ROS detection in the isolated perfused and
ventilated rabbit lungs, with particular attention being
paid to the autoxidation of CPH, we investigated the oxy-
gen-dependence of intravascular ROS release in the intact
lungs. Moreover, we quantified CPH oxidation over a
range of inspired oxygen concentrations, while stimulat-
ing NADPH oxidases with phorbol-12-myristate-13-ace-
tate (PMA). These experiments were performed in the
absence and presence of superoxide dismutase (SOD) to
estimate the proportion of superoxide-induced CPH oxi-
dation. We thus demonstrated the feasibility of the ESR
technique, and obtained interesting new insights into the
oxygen-dependence of baseline versus PMA/NADPH oxi-
dase-dependent superoxide generation in the intact lung
vasculature.
Methods
Chemicals and reagents
l-hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine
(CPH) was purchased from L-Optik (Berlin, Germany).
Krebs-Henseleit buffer contained 125.0 mM NaCl, 4.3
mM KC1, 1.1 mM KH2PO4, 2.4 mM CaCl2, 1.3 mM MgCl2
and 275 mg glucose per 100 ml. FeCl2, deferoxamine
(DFO), diethyldithiocarbamate (DETC), phorbol-12-
myristate-13-acetate (PMA), and Cu/Zn-superoxide dis-
mutase (SOD) were obtained from Sigma (Deisenhofen,
Germany). Apocynin was from Merck Biosciences
(Schwalbach, Germany).
In-vitro CPH experiments
For studying CPH characteristics and the effect of metal
chelating agents on background ESR signals, experiments
were performed in glass tubes containing 1 mM CPH solu-
tion prepared in Krebs-Henseleit buffer at room tempera-
ture. The iron chelator DFO was added in the
concentrations 20 µM or 2 mM to the solution and meas-
urements were run every 30 min for a total period of 5 h.
Isolated rabbit lung experiments
The technique of isolated lung perfusion and ventilation
has been described previously in detail [31,32]. Briefly,
pathogen-free New Zealand white rabbits of either sex
(body weight 2.5–3.2 kg) were deeply anesthetized with
ketamine (30–50 mg/kg body weight) and xylazine (6–10
mg/kg body weight), and anticoagulated with heparin
(1000 U/kg body weight). The lungs were excised whileRespiratory Research 2005, 6:86 http://respiratory-research.com/content/6/1/86
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perfused with Krebs-Henseleit buffer through cannulas in
the pulmonary artery and the left atrium. After the lungs
were rinsed with at least 1 1 of buffer fluid for removal of
blood, the perfusion circuit was closed for recirculation
(total system volume 150 ml) and left venous pressure set
at 2 mmHg to secure West zone III conditions for per-
fusion. In parallel with the onset of artificial perfusion,
room air ventilation was changed to a mixture of 5.3 %
CO2, 21.0 % O2 and the balance N2 (tidal volume, 30 ml;
frequency, 30 strokes/min) with the use of positive end-
expiratory pressure of 1 cm H2O. The pH was adjusted to
7.35 – 7.40 by addition of NaHCO3. The isolated lungs
were placed in a temperature-equilibrated housing cham-
ber and the whole system was heated to 38.5°C.
Krebs-Henseleit buffer was incubated with 5 µM diethyl-
dithiocarbamate overnight to allow sedimentation.
Briefly before the experiments, 20 µM DFO and NaHCOs
were added to the supernatant.
Lungs included in the study were those that i) had a
homogeneous white appearance with no signs of hemos-
tasis, edema or atelectasis, ii) revealed constant mean pul-
monary artery and peak ventilation pressure in the
normal range, and iii) were isogravimetric during the ini-
tial perfusion period of 55 min.
For normoxic and hypoxic ventilation maneuvers, a gas-
mixing chamber (KM 60-3/6 MESO, Witt, Witten, Ger-
many) was employed for step changes in the ventilator O2
content. 5.3 % CO2 were used throughout and the per-
centage of N2 was balanced accordingly.
After the initial steady state period with normoxic ventila-
tion (21 % O2), CPH (1 mM) was added to the buffer
fluid. Five minutes later, one of three different protocols
was initiated:
1) A 2.5 or 3.0 h period of normoxic ventilation with 21
% O2, in the case of a 3 h ventilation period followed by
a bolus application of PMA into the pulmonary artery,
resulting in a concentration of 1 µM in the recirculating
buffer fluid. Control experiments received a bolus of
saline instead of PMA,
2) Consecutive 30 min periods of ventilation with differ-
ent O2 concentrations (21, 16, 10, 5, 2.5 or 1 % O2 in a
randomized fashion) for a total period of 3 h, or
3) One 30 min-period of ventilation at either 21, 16, 10,
5, 2.5 or 1 % O2, followed by a bolus application of PMA
into the pulmonary artery, resulting in a concentration of
1 µM in the recirculating buffer fluid. Control experiments
received a bolus of NaCl instead of PMA.
In a portion of the experiments a fiber oxygenator (Hilite
1000, Stolberg, Germany) was used instead of the lung for
oxygenation of the buffer fluid.
Isolated mouse lung experiments
Mouse lung experiments were performed in a protocol
analogous to the isolated rabbit lung experiments but in
an in-chest preparation as previously described [33].
Lungs were perfused with 0.5 mM CPH at a flow rate of
2.0 ml/min for 120 min at normoxic ventilation (21
%O2), followed by a bolus application of PMA into the
buffer fluid, resulting in a concentration of 10 µM. For
these investigations either C57/BL6 mice (= wildtype con-
trol) or mice lacking the NADPH oxidase subunit
gp91phox (= p91phox-/-). Mice were obtained from The
Jackson Laboratory (Bar Harbor, Maine, USA).
ESR measurements
Oxidation of the spin probe CPH by superoxide forms the
nitroxide CP radical. The triple-line spectrum of CP radi-
cal was detected by ESR spectroscopy, using a MS 100
spectrometer (Magnettech, Berlin, Germany). The ESR
measurements were performed in field scan with the fol-
lowing settings: microwave frequency 9.78 GHz, modula-
tion frequency 100 kHz, modulation amplitude 2 G,
microwave power 18 mW. All samples, both from the in
vitro experiments or from the venous outflow of the iso-
lated lung, were made in 50 µl glass capillary tubes and
measured immediately at room temperature. The ESR
amplitude is in proportion to the amount of CP•, reflect-
ing the interaction of ROS with CPH [29,34,35]. Thus, the
quantity of trapped ROS was directly calculated from the
ESR spectrum of the probe, while the contribution of
superoxide radical to the formation of CP was determined
in parallel experiments performed in the presence of SOD
in the buffer fluid (150 U/ml). The first sample was taken
5 min after CPH addition to the buffer fluid (time set at
zero), followed by further sampling every 5 or 30 minutes,
as appropriate. The values after PMA addition were
assessed every minute in the respective experiments. In
the isolated mouse lung samples were taken every 2 min.
For quantification, the second-field component of the
ESR spectrum was used. To standardize values, the ampli-
tude of this component was divided through the receiver
gain.
Statistical analysis
Data are given as mean ± standard error (SEM). For com-
parison of two groups, a two-tailed t-test was employed.
For multiple comparisons, analysis of variance was used,
followed by the Student-Newman-Keuls post hoc test
when differences were indicated. Statistical significance
was assumed when p < 0.05.Respiratory Research 2005, 6:86 http://respiratory-research.com/content/6/1/86
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Results
When CPH (1 mM) was dissolved in Krebs-Henseleit
buffer ESR spectroscopy resulted in a triple band spectrum
(Fig. 1A). The ESR signal increased to 87.06 ± 11.17 arbi-
trary units, (AU, n = 8) within 5 h when incubated in-vitro
at room temperature (Fig. 1B). The presence of the iron
chelating agent DFO at a concentration of 20 µM or 2
mM, from the beginning of the experiment, reduced the
ESR amplitude ~8-fold to 11.66 ± 0.44 (n = 5) or 9.28 ±
0.57 (n = 4) AU within 5 h, with no major difference
being observed between the high and the low concentra-
tion of DFO (Fig. 1B). Pre-incubation of the buffer with
the copper chelator DETC (5 µM) further reduced the
increase in signal (data not shown). In line with these in
vitro data, ESR signal intensity increased when isolated
rabbit lungs were perfused under normoxic ventilation
with CPH (1 mM) for 2.5 h (Fig. 2). Perfusion with FeCl2
(1 µM) resulted in a markedly higher ESR signal intensity
(Fig. 2). Addition of H2O2 to the buffer fluid (8 µmol/
min, started after 1.5 h), in the presence of FeCl2, induced
a strong increase in ESR signal intensity, reaching a value
of 707.14 ± 103.15 AU (n = 4) within 1 h of lung per-
fusion (Fig. 2).
Performing a sequential mode of 30 min periods of venti-
lation maneuvers with different inspiratory oxygen con-
centrations (1 % – 21 % O2) revealed oxygen-dependent
changes in ESR signal intensity. The ESR signals demon-
strated a linear increase during the last 20 min of each
maneuver with samples taken every 5 min. This time-
dependent increase in the ESR signal intensity was highest
when ventilating the lungs with 21 % O2 and lowest when
ventilating the lungs with 2.5 % O2 (Fig. 3A). There was a
tendency towards increased values found when the lungs
were ventilated with 1 % O2, compared with 2.5 % O2.
Parallel experiments in the presence of SOD (150 U/ml),
revealed that a portion of the signal was derived from
superoxide. Figure 3B depicts the effect of the ventilation
maneuvers with the different oxygen concentrations on
pulmonary artery pressure (PAP). Hypoxic ventilation
induced an increase in PAP, which was highest at 1 % and
lowest at 16 % O2.
In Fig. 4A, the time-dependent increase of CP• formation
is illustrated for long-term normoxic ventilation (3 h,
21% O2) of isolated lungs. After 3 h, a bolus of PMA,
resulting in a concentration of 1 µM in the recirculating
buffer fluid, was injected into the pulmonary artery. This
application induced a rapid increase in the ESR signal
intensity, which was almost entirely blocked by the addi-
tion of SOD. As the time-dependent increase in ESR signal
intensity was linear before and after addition of PMA,
increase rates, pre-and post-intervention, may be directly
compared (Fig. 4B). While almost fully suppressed by
SOD, a five-fold increase in CP• formation per unit time
occurred in response to the PMA stimulation. For con-
trols, we performed corresponding experiments, in which
the lung was replaced by a fiber oxygenator, in order to
exclude a direct effect of PMA on CPH oxidation. No
response to PMA was observed in the absence of the lung
vasculature either in the presence or in the absence of 1
µM FeCl2 (Fig. 4B).
The PMA-induced increase in ESR signal intensity in the
isolated lung experiments was inhibited by the NADPH
oxidase inhibitor apocynin but not by rotenone, an inhib-
itor of mitochondrial complex I (Fig. 5A). Moreover, in
mice lacking the NADPH oxidase subunit gp91phox, the
PMA-induced increase in the ESR signal intensity was pre-
vented, when compared to wildtype mice (Fig. 5B). Corre-
sponding to the SOD-inhibitable increase in ESR signal
intensity in the perfused rabbit lungs, PMA application
induced a vasoconstrictor response, which was also
largely attenuated in the presence of SOD as well as in the
presence of apocynin (table 1).
To investigate the effect of inspired oxygen concentration
on the PMA-induced increment in CP• formation, we per-
formed short-term ventilation periods of 30 min at vary-
ing O2 concentrations, followed by bolus application of
PMA (1 µM) into the pulmonary artery. The increases in
the ESR signal intensity/min post-PMA was compared to
that pre-PMA application (Fig. 6A). The highest increase
in ESR signal intensity/time was observed when the lungs
were ventilated with 5 % O2, within a total range of 1 – 21
% O2. Parallel experiments in the presence of SOD,
revealed that the major portion of the increase in the ESR
signal was due to superoxide release. Again, replacement
of the lungs by a fiber oxygenator, to equilibrate the buffer
fluid with the different oxygen concentrations did not
change the increase rate in ESR signal intensity after PMA
application, either in the absence or in the presence of 1
µM FeCl2 (Fig. 6A). PMA application induced an increase
in PAP (Fig. 6B). This increase was highest when lungs
were ventilated with 5 % O2.
Discussion
Methodological aspects
Because ROS formation has been implicated in a variety of
lung diseases, the detection of ROS release from the pul-
monary circulation is thought to be important [7-9].
However, current methods for the detection of lung vascu-
lar ROS formation lack specificity due to autoxidation of
the substrates employed, the lack reliability due to artifi-
cial ROS generation by redox cycling [22,24,25], and a
lack sensitivity of the techniques employed. The ESR tech-
nology may overcome several of these shortfalls. In a pre-
vious study, Katz and colleagues used spin trapping and
ESR technology for ROS detection in isolated perfused
rabbit lungs. However, in that investigation, the spinRespiratory Research 2005, 6:86 http://respiratory-research.com/content/6/1/86
Page 5 of 15
(page number not for citation purposes)
The effect of the iron chelating agent deferoxamine (DFO) on CP• nitroxide signal intensity in vitro Figure 1
The effect of the iron chelating agent deferoxamine (DFO) on CP• nitroxide signal intensity in vitro. (A) Typical 
ESR spectrum of CP• nitroxide resulting from the reaction of the hydroxylamine spin probe CPH with ROS. The height of the 
first field component of the triple-line spectrum was used for quantification of signal intensity. (B) In-vitro incubation of CPH (1 
mM) in Krebs-Henseleit buffer. Signal intensity is given in arbitrary units (AU). Data are shown for CPH oxidation in the 
absence (-DFO) or in the presence of either 20 µM or 2 mM deferoxamine (DFO). Asterisks indicate significant differences 
when compared to the-DFO group.
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probe was added to the lung effluent, and was therefore
unable to detect ROS release at its source within the vas-
culature, which would be desirable due to the short half-
life of ROS [27]. We therefore favored the strategy to add
the spin probe directly to the buffer fluid, and employed
the cyclic hydroxylamine spin probe CPH, as this is an
effective ROS scavenger allowing quantitative measure-
ment of ROS formation [29,30]. Even under conditions of
hypoxia-induced vasoconstriction the spin probe is
expected to reach all parts of the lungs as these were per-
fused at constant flow under zone III conditions [31]. The
reaction rate constant of CPH with ROS is 3.2 × 103 M-1 s-
1, which is approximately 10-fold higher than the reaction
rate constant of nitrone spin traps such as DMPO or
DEPMPO [30,36]. The incorporation of CPH into the cell
membrane is low, permitting analysis of extracellular ROS
release, while the high stability of the formed nitroxides
allowed quantitative measurement of the reaction prod-
uct in the lung effluent [30,35].
CPH was, however, reported to be autoxidized through
traces of transition metals, such as iron and copper, which
can be eliminated by chelators [37]. Therefore, we first
characterized CPH properties incubated in vitro in Krebs-
Henseleit-buffer, which is routinely used for perfusion of
the isolated lungs. Measurement of aliquots from this
solution resulted in the typical triple-band spectrum
[29,30]. The prominent reduction in the increased ESR
signal intensity observed within a five-hour incubation
period, in the presence of the iron chelator DFO, con-
firmed autoxidation of CPH catalyzed by traces of transi-
tion metals in the buffer fluid. This interpretation is also
supported by the observation that the increase in signal
intensity during perfusion of CPH through the lung is fur-
ther enhanced by the addition of FeCl2 to the buffer fluid.
No major difference was found between low and high
DFO concentrations, and preincubation of the buffer with
the copper chelator DETC further reduced CPH autoxida-
tion. We therefore conducted all subsequent experiments
The ESR signal intensity in isolated perfused and ventilatedrabbit lungs during baseline conditions and in the presence of FeCl2/ H2O2 Figure 2
The ESR signal intensity in isolated perfused and ventilatedrabbit lungs during baseline conditions and in the 
presence of FeCl2/H2O2. Lungs were either perfused with Krebs-Henseleit buffer containing 1 mM CPH only (control) or in 
the presence of FeCl2 (1 µM, added at 0.5 h, FeCl2/H2O2). After 1.5 h, H2O2 was added to the buffer fluid by continuous infu-
sion (8 µmol/min) in the FeCl2-perfused lungs. Bar indicates significant differences between the FeCl2/H2O2 group and control.
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Hypoxia-dependent superoxide release and vasoconstrictor responses in isolated perfused and ventilated rabbit lungs Figure 3
Hypoxia-dependent superoxide release and vasoconstrictor responses in isolated perfused and ventilated rab-
bit lungs. During a total 3 h period of perfusion, the ventilator gas supply was switched to different oxygen concentrations 
every 30 min, using 1 %, 2.5 %, 5 %, 10 %, 16 % or 21 % O2 in a randomized mode. (A) Superoxide release. The rate of increase 
in ESR signal intensity turned out to be linear during the last 20 min of each ventilation period. Therefore, changes in the ESR 
signal intensity/min during the last 20 min of each ventilation period are given. In the +SOD group, 150 mU/ml superoxide dis-
mutase (SOD) was present throughout the experiments. * significant differences between the +SOD and the -SOD group for 
the respective oxygen concentration. ** significant differences as compared to 21 % O2. (B) Vasoconstrictor response. The 
maximum increases in PAP (∆ PAP) are given for the different oxygen concentrations and are referenced to baseline (=nor-
moxic) PAP values, which were 8.8 ± 0.6 mmHg
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Superoxide release from isolated perfused rabbit lungs afteraddition of phorbol-12-myristate-13-acetate (PMA) during nor- moxic ventilation Figure 4
Superoxide release from isolated perfused rabbit lungs afteraddition of phorbol-12-myristate-13-acetate 
(PMA) during normoxic ventilation. (A) ESR signal intensity during normoxic ventilation of rabbit lungs in the presence 
(+SOD) and the absence of SOD (-SOD). After 3 h, PMA was injected into the pulmonary artery, resulting in a concentration 
of 1 µM in the recirculating buffer fluid. The increase in ESR signal intensity was linear before and after addition of PMA. The 
insert shows the PMA effect with higher time resolution. (B) Changes in the increase rate of the ESR signal intensity (%) by 
comparison of values prior to and after addition of PMA to isolated rabbit lungs. In the +SOD group, SOD was present 
throughout the experiments. In two separate sets of experiments, a fiber oxygenator was used instead of the lung for oxygen-
ation of the recirculating buffer fluid ("fiber oxygenator"). The fibre oxygenator experiments were performed either in the 
absence ("fiber oxygenator") or in the presence of 1 µM FeCl2 ("fiber oxygenator + FeCl2") in the buffer fluid. * significant dif-
ference between the +SOD and the -SOD group
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Effects of the NADPH oxidase and mitochondrial inhibitors, as well as of phagocytic NADPH oxidase gene deletion on the ESR  signal intensity in isolated perfused lungs after addition of phorbol-12-myristate-13-acetate (PMA) during normoxic ventilation Figure 5
Effects of the NADPH oxidase and mitochondrial inhibitors, as well as of phagocytic NADPH oxidase gene 
deletion on the ESR signal intensity in isolated perfused lungs after addition of phorbol-12-myristate-13-ace-
tate (PMA) during normoxic ventilation. (A) Effect of the NADPH oxidase inhibitor apocynin (500 µM) and the inhibitor 
of mitochondrial complex I, rotenone (350 nM) on the increase rate in ESR signal intensity after addition of PMA. Each inhibitor 
was added to the buffer fluid 30 min before addition of PMA. In the +SOD group, SOD was present throughout the experi-
ments. * significant difference as compared to control. (B) Comparison of the increase rate in ESR signal intensity after addition 
of PMA in wildtype (WT) and gp91phox-deficient (gp91phox-/-) mice. Lungs were perfused for 120 min prior to PMA addition 
(10 µM) either in the presence or absence of 150 U/ml SOD. * significant difference as compared to WT. Data are given as 
changes in the increase rate of the ESR signal intensity after PMA addition, as compared to the values before PMA addition (set 
as 100%). Data are from n = 4–5 experiments for each group.
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in the presence of 20 µM DFO after preincubation of the
buffer with DETC (5 µM). The DETC inhibits Cu, Zn -
SOD. However, inhibition was only observed when much
higher concentrations (>1 mM) were applied compared
with the concentration employed in our study [38]. These
findings are supported by other investigations from our
laboratory, demonstrating that HPV in isolated rabbit
lungs is not altered even at DECT concentrations 20 times
higher than those employed in the present study [21].
When the DFO-and DETC-treated buffer was employed
for perfusion of isolated and ventilated rabbit lungs, we
first demonstrated that CPH is suitable for detection of
ROS by the admixture of H2O2 to the buffer fluid, which
resulted in a prominent increase in ESR signal intensity.
This increase is most likely related to the generation of
hydroxyl radicals (OH•) via Fenton reaction [39-41].
Although these data demonstrate the suitability of the
technique, it became apparent that continuous oxidation
of CPH circulating through the lungs occurs, which may
depend on ongoing ROS release, or may reflect autoxida-
tion independent of lung ROS liberation.
Oxygen-dependency of superoxide release
To investigate the dependency of the ESR signal increase
on the inspired oxygen concentration, successive 30 min
ventilation periods with different O2 concentrations of the
inspired gas were performed. We found a decreased rate of
ESR signal enhancement at lower oxygen concentrations,
with a minimum at 2.5 % O2, whereas 1 % O2 caused
again some increase. Addition of SOD to the buffer fluid
reduced the rate of ESR signal increase at all oxygen con-
centrations, proving that at least a portion of the ESR sig-
nal detected is caused by intravascular superoxide release
from the lungs. Several enzyme systems may be responsi-
ble for oxygen-dependent release of superoxide into the
lung vasculature, including the NADPH-oxidases, xan-
thine-oxidase, nitric oxide synthases and arachidonic acid
oxygenase pathways, as well as the mitochondrial respira-
tory chain [9,13,14,20]. Moreover, non-superoxide-
derived ROS may add to the baseline increase in CPH
oxidation, not suppressed by SOD [35]. As extracellular
SOD is not thought to enter the intracellular milieu
[42,43], intracellular trapping of superoxide by CPH may
further add to this finding. However, as only low penetra-
tion of cell membranes was described for CPH this is less
likely [34,44,45].
Ventilation of the lungs with oxygen concentrations lower
than 21 % resulted in increased pulmonary artery pres-
sure, with the changes in proportion to the relative O2
decrease being highest between 10.0 and 2.5 %, as previ-
ously reported for isolated rabbit lungs [31]. This
hypoxia-induced vasoconstriction is known as a key fea-
ture of the lung, matching perfusion to ventilation in
order to optimize pulmonary gas exchange by excluding
poorly or non-ventilated areas from blood flow. Among
other concepts, lung ROS generation has been suggested
to be involved in this mechanism [15,46]. However, there
is ongoing discussion about whether an increase or a
decrease in ROS occurs during hypoxia, and from what
source hypoxia-induced ROS may be derived
[12,14,17,18,20,21]. As possible sources for both a
decrease and an increase, mitochondria or NADPH-oxi-
dases have been suggested [8,12]. With regard to these
aspects it has not yet been determined whether hypoxia
can indeed cause a paradoxical increase in NADPH oxi-
dase-dependent superoxide release in the pulmonary
circulation. The fact that extracellular SOD inhibited the
ESR signal, but not the PAP increase under hypoxic condi-
tions [8,32] can be explained by intracellular superoxide
production, e.g. in the vascular smooth muscle cells,
underlying the mechanism of hypoxic vasoconstriction,
but not being a major contributor to the intravascular
superoxide leak. Thus, the current focus on the intravascu-
lar compartment for ROS trapping may not be a suitable
approach for analyzing ROS formation that underlies
hypoxic pulmonary vasoconstriction. It may, however, be
appropriate to measure ROS formation under conditions
primarily affecting the endothelial cells, such as endothe-
Table 1: Baseline pulmonary artery pressure (PAP) and phorbol-12-myristate-13-acetate (PMA)-induced changes in PAP after 3 hours 
of normoxic ventilation. Pulmonary artery pressure values (PAP) are given for time points directly before and 6 min after addition of 
PMA to the buffer fluid. In addition, the increase in PAP per minute (∆ PAP/min) after PMA addition is indicated. Data are shown for 
experiments in the absence (-SOD) and the presence of 150 U/ml superoxide dismutase (+SOD). The PMA was added after 3 h of 
normoxic ventilation. Values of the +SOD and -SOD group correspond to experiments in Fig. 4. In the apocynin group this agent was 
present in the perfusate at a concentration of 500 µM. In experiments without addition of PMA, no significant change in PAP was 
observed within 6 min after PMA addition. Asterisk indicates significant difference of the -SOD as compared to the +SOD or apocynin 
group.
directly before PMA [mmHg] 6 min after PMA ∆ PAP/min after PMA n
-SOD 10.4 ± 0.4 15.2 ± 1.1 0.66 ± 0.18 5
+SOD 8.9 ± 0.7 9.9 ± 0.7 0.15 ± 0.02 4 *
apocynin 8.2 ± 0.4 8.3 ± 1.0 0.03 ± 0.01 4 *Respiratory Research 2005, 6:86 http://respiratory-research.com/content/6/1/86
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Oxygen-dependency of PMA-induced changes in ESR signal intensity, lung superoxide release, and pulmonary artery pressure Figure 6
Oxygen-dependency of PMA-induced changes in ESR signal intensity, lung superoxide release, and pulmonary 
artery pressure. Lungs were ventilated for 30 minutes with either 1 %, 2.5 %, 5 %, 10 %, 16 % or 21 % O2, followed by injec-
tion of PMA into the pulmonary artery, resulting in a concentration of 1 µM in the recirculating buffer fluid. (A) Changes in the 
increase rate of the ESR signal intensity after PMA addition, as compared to the values before PMA addition (set as 100 %) are 
given. Experiments were performed in the presence (+SOD) or the absence (-SOD) of SOD. In the control group, lungs were 
replaced by a fiber oxygenator for equilibration of the buffer fluid with the different oxygen concentrations. The fibre oxygena-
tor experiments were performed either in the absence or in the presence of 1 µM FeCl2 in the buffer fluid. * significant differ-
ences between +SOD and -SOD groups. ** significant differences between different oxygen concentrations. (B) Increase in 
pulmonary artery pressure per minute (∆ PAP/min) within 7 min after PMA addition to the buffer fluid. In experiments without 
addition of PMA no significant change in PAP was observed. Data are from n = 4–9 experiments for each group.
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lial injury and ischemia-reperfusion conditions.
Therefore, we targeted key enzyme systems that may be
involved in endothelial ROS generation.
NADPH oxidase-dependent superoxide release and 
pulmonary vasoconstriction
To provoke a more pronounced ROS formation in the vas-
cular compartment and to investigate the oxygen-depend-
ence of NADPH oxidase-derived superoxide release, we
employed intravascular administration of PMA, which
was previously shown to stimulate NADPH oxidases via
activation of protein kinase C [27]. Indeed, PMA induced
a prominent increase in the rate of CPH oxidation, mostly
attributable to intravascular superoxide release, as evident
from a total block of this increase in the presence of SOD.
Replacement of the lung by a fiber oxygenator to mimic
oxygenation of the buffer fluid, as would occur in the
lung, assured that no lung-independent oxidation of CPH
was provoked by PMA, neither in the absence nor in the
presence of FeCl2. Thus an overlapping effect of metal
ions primarily being responsible for the oxygen-depend-
ent effects seen in the presence of the lung as e.g. results
from a Fenton reaction, can be excluded. The PMA-
induced increase in the ESR signal was illustrated in our
study to be attributable to the suggested pathway of
NADPH oxidase stimulation, because it was prevented a)
by the NADPH oxidase inhibitor apocynin as well as b) in
mice lacking the NADPH oxidase subunit gp91phox
(Nox-2). In contrast, rotenone, a mitochondrial complex
I inhibitor, did not affect the PMA induced ROS release.
This indicated that mitochondria-derived superoxide does
not play a role in the oxygen-dependent ROS release
induced by PMA. This finding is of particular interest,
given the recent reports of mitochondria as possible
sources of superoxide release [17]. Moreover, PMA caused
an immediate pulmonary artery pressor response, which
was also largely blocked by SOD, suggesting a direct vaso-
constrictor effect of superoxide generated by PMA addi-
tion. This suggestion is in line with the inhibition of the
vasoconstrictor response by the NADPH oxidase inhibitor
apocynin. The fact that PMA stimulation of the lung
induces a vasoconstrictor response via superoxide chal-
lenges previous studies suggesting that the PMA-induced
vasoconstrictor response involves a Ca2+ sensitization by
inhibition of myosin light chain phosphatase (for review
see [47]). The superoxide-induced vasoconstriction in this
pathway may involve intracellular calcium mobilization
by enhancing cyclic ADP-ribose production [48], activa-
tion of RhoA/Rho kinase [49], or inactivation of NO [50]
by superoxide. To investigate the oxygen-dependence of
the PMA-induced superoxide release, we then stimulated
the lungs with PMA in the presence of different oxygen
concentrations. Most interestingly, we detected peak
PMA-evoked lung superoxide release when lungs were
ventilated with 5 % O2. This peak in superoxide release
correlated with the maximum PMA-evoked
vasoconstrictor effect. The NADPH oxidases of endothe-
lial cells, which have been shown to contain all NADPH
oxidase subunits needed for superoxide generation as well
as leukocytes are resident in the intravascular compart-
ment, and are suggested as a possible source of the PMA-
induced superoxide release. The ESR technology was not
suitable for detecting significant hypoxia-dependent
changes in superoxide release in unstimulated isolated
rabbit lungs. However, since i) hypoxia caused an
increased release of NADPH-dependent superoxide
release when lungs were challenged with PMA and ii) that
superoxide caused a vasoconstriction; it is tempting to
speculate that such mechanisms may contribute to the
regulation of HPV. Data from our laboratory have repeti-
tively suggested that an NADPH oxidase-dependent
increase in lung ROS release contributes to the initiation
of HPV [8,21]. Thus, it is interesting that many studies
investigating HPV in isolated lungs the pulmonary circu-
lation was primed with angiotensin II to yield a sufficient
hypoxic vasoconstrictor response [51-53]. Angiotensin II
has also been shown to activate NADPH oxidases and
thus a possible interference of an angiotensin II-induced
superoxide release in HPV has to be taken into account.
The increase in NADPH oxidase-dependent superoxide
release may not only play a role under physiological con-
ditions, but may also contribute to pathophysiological
pathways in conditions of ischemia-reperfusion, implicat-
ing not only a role of superoxide during reperfusion
phase, but also in the ischemic phase.
Three distinct effects have to be taken into consideration
regarding the mechanism of PMA-induced increase in
intravascular superoxide release. First, a direct effect of
hypoxia on the activity of NADPH oxidases. Although
such an effect is not known for the NADPH oxidases from
phagocytic cells, this may not be excluded for vascular
NADPH oxidases that are composed of specific isoforms
[54]. Thus, regulation of electron flux through the
NADPH oxidase rather than oxygen itself (even at low
concentrations) may be the rate-limiting step in superox-
ide formation. This suggestion is supported by the notion
that NADPH oxidase-dependent superoxide release is
stimulated by anoxia in cultured aortic endothelial cells
[55]. Second, the increased superoxide release may be
related to alterations in the activation mechanism
upstream of NADPH oxidase (e. g. protein kinase c) or
may be related to alterations in protein kinase c-inde-
pendent mechanisms of NADPH oxidase assembly [55].
Third, alterations to the intravascular or cellular oxygen
scavenging capacity may also contribute to an increased
superoxide release in hypoxia.Respiratory Research 2005, 6:86 http://respiratory-research.com/content/6/1/86
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Conclusion
In summary, we have established a new method to detect
intravascular ROS release in intact lungs, combining ESR
technology with lung perfusion in the presence of the spin
probe CPH. This technique may be useful in elucidating
the role of ROS in different physiological and
pathophysiological conditions where ROS are suggested
to be involved and to correlate ROS release to vasoreactiv-
ity. Focusing on hypoxia-dependent ROS release, we dem-
onstrated that i) that PMA-induced vasoconstriction is
caused by superoxide generated from NADPH oxidases
(rather than by H2O2 or by a protein kinase c-dependent
increase in Ca2+ sensitivity) and ii) that this pathway is
pronounced in hypoxia. The NADPH oxidases thus may
contribute the hypoxia-dependent regulation of pulmo-
nary vascular tone.
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